N E U R O - C E L L S®
Neuro-Cells® is the only therapy based on naïve (“untouched”) stem cells, produced through a proprietary, IP-protected manufacturing process.
The Neuro-Cells® autologous platform therapy targets the fundamental cellular processes shared across neurodegenerative diseases.
Our technology harnesses the body’s own regenerative potential through minimally manipulated stem cells — the patient’s natural cellular repair toolkit.
​
In neurodegenerative conditions, this repair capacity cannot be effectively activated due to the protective blood–brain barrier.
Neuro-Cells® overcomes this limitation by delivering therapeutic cells directly to the central nervous system.
Neuro-Cells® contains a unique mixture of untouched stem cells that intrinsically “know” how to respond to failing cellular pathways. Acting in close coordination, these cells restore balance within the neurodegenerative environment — a key differentiator of the Neuro-Cells® therapy compared with conventional approaches.​
Neuroplast has developed Neuro-Cells® as an EU-GMP-compliant autologous cell therapy.
Neuro-Cells® is manufactured from a patient’s own bone marrow and administered directly into the cerebrospinal compartment via lumbar injection.
Neuro-Cells® has successfully completed Phase I and Phase II clinical trials in spinal cord injury with demonstrated benefits and safety.